Summary
Cushing’s disease is a serious endocrinopathy that if untreated greatly increases morbidity and carries a fourfold increase in mortality, largely related to associated cardiovascular complications and abnormal glucose metabolism. This chapter discusses the surgical management of Cushing’s disease, including surgical techniques, complications, and outcomes, as well as the management of residual or recurrent disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88:5593–602.
Boscaro M, Barzon L, Fallo F, et al. Cushing’s syndrome. Lancet 2001;357:783–91.
Newell-Price J. Transsphenoidal surgery for Cushing’s disease: defining cure and following outcome. Clin Endocrinol (Oxf) 2002;56:19–21.
Orth DN. Cushing’s syndrome. N Engl J Med 1995;332:791–803.
Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 1995;80:3114–20.
Etxabe J, Vazquez JA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994;40:479–84.
Lindholm J, Juul S, Jorgensen JO, et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 2001;86:117–23.
Chen JC, Amar AP, Choi S, et al. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 2003;98:967–73.
Flitsch J, Knappe UJ, Ludecke DK. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing’s disease. Zentralbl Neurochir 2003;64:6–11.
Mampalam TJ, Tyrrell JB, Wilson CB. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 1988;109:487–93.
Pereira AM, van Aken MO, van Dulken H, et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease. J Clin Endocrinol Metab 2003;88:5858–64.
Shimon I, Ram Z, Cohen ZR, et al. Transsphenoidal surgery for Cushing’s disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 2002;51:57–61; discussion 61–52.
Sonino N, Zielezny M, Fava GA, et al. Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab 1996;81:2647–52.
Yap LB, Turner HE, Adams CB, et al. Undetectable postoperative cortisol does not always predict long-term remission in Cushing’s disease: a single centre audit. Clin Endocrinol (Oxf) 2002;56:25–31.
Hammer GD, Tyrrell JB, Lamborn KR, et al. Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results. J Clin Endocrinol Metab 2004;89: 6348–57.
Mancini T, Kola B, Mantero F, et al. High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 2004;61:768–77.
Pikkarainen L, Sane T, Reunanen A. The survival and well-being of patients treated for Cushing’s syndrome. J Intern Med 1999;245:463–8.
Grabner P, Hauer-Jensen M, Jervell J, et al. Long-term results of treatment of Cushing’s disease by adrenalectomy. Eur J Surg 1991;157:461–4.
Ludecke DK, Niedworok G. Results of microsurgery in Cushing’s disease and effect on hypertension. Cardiology 1985;72 Suppl 1:91–4.
Swearingen B, Biller BM, Barker FG 2nd, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999;130:821–4.
Findling JW, Raff H. Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 1999;28:191–210.
Aron DC, Raff H, Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1997;82:1780–5.
Wiggam MI, Heaney AP, McIlrath EM, et al. Bilateral inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome: a comparison with other diagnostic tests. J Clin Endocrinol Metab 2000;85:1525–32.
Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 1991;325:897–905.
Blevins LS Jr, Christy JH, Khajavi M, et al. Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 1998;83:63–7.
Patronas N, Bulakbasi N, Stratakis CA, et al. Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors. J Clin Endocrinol Metab 2003;88:1565–9.
Semple CG. Transsphenoidal surgery for Cushing’s disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery 2000;46:553–8; discussion 558–9.
Gao R, Isoda H, Tanaka T, et al. Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images. Eur J Radiol 2001;39:139–46.
Smallridge RC, Czervionke LF, Fellows DW, et al. Corticotropin- and thyrotropin-secreting pituitary microadenomas: detection by dynamic magnetic resonance imaging. Mayo Clin Proc 2000;75:521–8.
Tabarin A, Laurent F, Catargi B, et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing’s disease. Clin Endocrinol (Oxf) 1998;49:293–300.
Tomczak R, Merkle E, Fiala S, et al. [Value of dynamic MRI in the diagnosis of hypophyseal microadenomas]. Rofo 1998;168:488–92.
Drake WM, Perry LA, Hinds CJ, et al. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing’s syndrome and peritonitis. J Clin Endocrinol Metab 1998;83:3542–4.
Krakoff J, Koch CA, Calis KA, et al. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing’s syndrome. J Clin Endocrinol Metab 2001;86:4104–8.
Nieman LK. Medical therapy of Cushing’s disease. Pituitary 2002;5:77–82.
Schulte HM, Benker G, Reinwein D, et al. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing’s syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 1990;70:1426–30.
Hofmann BM, Fahlbusch R. Treatment of Cushing’s disease: a retrospective clinical study of the latest 100 cases. Front Horm Res 2006;34:158–184.
Sonino N, Boscaro M, Paoletta A, et al. Ketoconazole treatment in Cushing’s syndrome: experience in 34 patients. Clin Endocrinol (Oxf) 1991;35:347–52.
Tabarin A, Navarranne A, Guerin J, et al. Use of ketoconazole in the treatment of Cushing’s disease and ectopic ACTH syndrome. Clin Endocrinol (Oxf) 1991;34:63–9.
Bigos ST, Robert F, Pelletier G, et al. Cure of Cushing’s disease by transsphenoidal removal of a microadenoma from a pituitary gland despite a radiographically normal sella turcica. J Clin Endocrinol Metab 1977;45:1251–60.
Bigos ST, Somma M, Rasio E, et al. Cushing’s disease: management by transsphenoidal pituitary microsurgery. J Clin Endocrinol Metab 1980;50:348–54.
Hardy J. Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing’s disease: 50 years later. Can J Neurol Sci 1982;9:375–80.
Hardy J. The transsphenoidal surgical approach to the pituitary. Hosp Pract 1979;14:81–9.
Salassa RM, Laws ER Jr, Carpenter PC, et al. Transsphenoidal removal of pituitary microadenoma in Cushing’s disease. Mayo Clin Proc 1978;53:24–8.
Tyrrell JB, Brooks RM, Fitzgerald PA, et al. Cushing’s disease. Selective trans-sphenoidal resection of pituitary microadenomas. N Engl J Med 1978;298:753–8.
Carmalt MH, Dalton GA, Fletcher RF, et al. The treatment of Cushing’s disease by trans-sphenoidal hypophysectomy. Q J Med 1977;46:119–34.
Ludecke D, Kautzky R, Saeger W, et al. Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases. Acta Neurochir (Wien) 1976;35:27–42.
Netea-Maier RT, van Lindert EJ, den Heijer M, et al. Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing’s disease. Eur J Endocrinol 2006;154:675–84.
Knappe UJ, Ludecke DK. Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing’s disease. Acta Neurochir Suppl 1996;65:31–4.
Rollin GA, Ferreira NP, Junges M, et al. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing’s disease. J Clin Endocrinol Metab 2004;89:1131–9.
Esposito F, Dusick JR, Cohan P, et al. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 2006;91:7–13.
Rees DA, Hanna FW, Davies JS, et al. Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 2002;56:541–51.
Cannavo S, Almoto B, Dall’Asta C, et al. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol 2003;149:195–200.
Damiani D, Aguiar CH, Crivellaro CE, et al. Pituitary macroadenoma and Cushing’s disease in pediatric patients: patient report and review of the literature. J Pediatr Endocrinol Metab 1998;11:665–9.
Buchfelder M, Fahlbusch R. Neurosurgical treatment of Cushing’s disease in children and adolescents. Acta Neurochir Suppl (Wien) 1985;35:101–5.
Devoe DJ, Miller WL, Conte FA, et al. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 1997;82:3196–202.
Dyer EH, Civit T, Visot A, et al. Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 1994;34:207–12; discussion 212.
Kanter AS, Diallo AO, Jane JA Jr, et al. Single-center experience with pediatric Cushing’s disease. J Neurosurg 2005;103:413–20.
Knappe UJ, Ludecke DK. Transnasal microsurgery in children and adolescents with Cushing’s disease. Neurosurgery 1996;39:484–92; discussion 492–83.
Leinung MC, Kane LA, Scheithauer BW, et al. Long term follow-up of transsphenoidal surgery for the treatment of Cushing’s disease in childhood. J Clin Endocrinol Metab 1995;80:2475–9.
Magiakou MA, Mastorakos G, Oldfield EH, et al. Cushing’s syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994;331:629–36.
Partington MD, Davis DH, Laws ER Jr, et al. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg 1994;80:209–16.
Savage MO, Lienhardt A, Lebrethon MC, et al. Cushing’s disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 2001;55 Suppl 1:24–30.
Brand IR, Dalton GA, Fletcher RF. Long-term follow up of trans-sphenoidal hypophysectomy for Cushing’s disease. J R Soc Med 1985;78:291–3.
Thomas JP, Richards SH. Long term results of radical hypophysectomy for Cushing’s disease. Clin Endocrinol (Oxf) 1983;19:629–36.
Semple PL, Laws ER, Jr. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing’s disease. J Neurosurg 1999;91:175–9.
Chee GH, Mathias DB, James RA, et al. Transsphenoidal pituitary surgery in Cushing’s disease: can we predict outcome? Clin Endocrinol (Oxf) 2001;54:617–26.
Locatelli M, Vance ML, Laws ER. Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 2005;90: 5478–82.
Ram Z, Nieman LK, Cutler GB Jr, et al. Early repeat surgery for persistent Cushing’s disease. J Neurosurg 1994;80:37–45.
Hardy J. Cushing’s disease: pituitary microsurgery. Curr Ther Endocrinol Metab 1997;6:63–5.
Ludecke DK, Flitsch J, Knappe UJ, et al. Cushing’s disease: a surgical view. J Neurooncol 54:151–66.
Zada G, Kelly DF, Cohan P, et al. Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions. J Neurosurg 2003;98:350–8.
Griffith HB, Veerapen R. A direct transnasal approach to the sphenoid sinus. Technical note. J Neurosurg 1987;66:140–2.
Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg 2006;104:7–19.
Mesiwala AH, Farrell L, Santiago P, et al. The effects of hydrogen peroxide on brain and brain tumors. Surg Neurol 2003;59:398–407; discussion 407.
Dusick JR, Mattozo CA, Esposito F, et al. BioGlue for prevention of postoperative cerebrospinal fluid leaks in transsphenoidal surgery: A case series. Surg Neurol 2006;66:371–376; discussion 376.
Simmons NE, Alden TD, Thorner MO, et al. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 2001;95:1–8.
Brunicardi FC, Rosman PM, Lesser KL, et al. Current status of adrenalectomy for Cushing’s disease. Surgery 1985;98:1127–34.
Favia G, Boscaro M, Lumachi F, et al. Role of bilateral adrenalectomy in Cushing’s disease. World J Surg 1994;18:462–6.
Hardy JD, Moore DO, Langford HG. Cushing’s disease today. Late follow-up of 17 adrenalectomy patients with emphasis on eight with adrenal autotransplants. Ann Surg 1985;201:595–603.
Invitti C, Giraldi FP, de Martin M, et al. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999;84:440–8.
Kasperlik-Zaluska AA, Nielubowicz J, Wislawski J, et al. Nelson’s syndrome: incidence and prognosis. Clin Endocrinol (Oxf) 1983;19:693–8.
McCance DR, Russell CF, Kennedy TL, et al. Bilateral adrenalectomy: low mortality and morbidity in Cushing’s disease. Clin Endocrinol (Oxf) 1993;39:315–21.
Nagesser SK, van Seters AP, Kievit J, et al. Long-term results of total adrenalectomy for Cushing’s disease. World J Surg 2000;24:108–13.
Pereira MA, Halpern A, Salgado LR, et al: A study of patients with Nelson’s syndrome. Clin Endocrinol (Oxf) 1998;49:533–9.
Estrada J, Boronat M, Mielgo M, et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 1997;336:172–7.
Imaki T, Tsushima T, Hizuka N, et al. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing’s disease and determine which patients should be treated with pituitary irradiation after surgery. Endocr J 2001;48:53–62.
Vicente A, Estrada J, de la Cuerda C, et al. Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. Acta Endocrinol (Copenh) 1991;125:470–4.
Pollock BE, Kondziolka D, Lunsford LD, et al. Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir Suppl 1994;62:33–8.
Sheehan JM, Vance ML, Sheehan JP, et al. Radiosurgery for Cushing’s disease after failed transsphenoidal surgery. J Neurosurg 2000;93:738–42.
Degerblad M, Rahn T, Bergstrand G, et al. Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing’s disease. Acta Endocrinol (Copenh) 1986;112:310–14.
Littley MD, Shalet SM, Beardwell CG, et al. Long-term follow-up of low-dose external pituitary irradiation for Cushing’s disease. Clin Endocrinol (Oxf) 1990;33:445–55.
Murayama M, Yasuda K, Minamori Y, et al. Long term follow-up of Cushing’s disease treated with reserpine and pituitary irradiation. J Clin Endocrinol Metab 1992;75:935–42.
Nagesser SK, van Seters AP, Kievit J, et al. Treatment of pituitary-dependent Cushing’s syndrome: long-term results of unilateral adrenalectomy followed by external pituitary irradiation compared to transsphenoidal pituitary surgery. Clin Endocrinol (Oxf) 2000;52:427–35.
Kelly PA, Samandouras G, Grossman AB, et al. Neurosurgical treatment of Nelson’s syndrome. J Clin Endocrinol Metab 2002;87:5465–9.
Kemink SA, Grotenhuis JA, De Vries J, et al. Management of Nelson’s syndrome: observations in fifteen patients. Clin Endocrinol (Oxf) 2001;54:45–52.
Ludecke DK, Breustedt HJ, Bramswig J, et al. Evaluation of surgically treated Nelson’s syndrome. Acta Neurochir (Wien) 1982;65:3–13.
Wislawski J, Kasperlik-Zaluska AA, Jeske W, et al. Results of neurosurgical treatment by a transsphenoidal approach in 10 patients with Nelson’s syndrome. J Neurosurg 1985;62:68–71.
Xing B, Ren Z, Su C, et al. Microsurgical treatment of Nelson’s syndrome. Chin Med J (Engl) 2002;115:1150–2.
Cavagnini F, Pecori Giraldi F. Epidemiology and follow-up of Cushing’s disease. Ann Endocrinol (Paris) 2001;62:168–72.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this chapter
Cite this chapter
Kelly, D.F. (2008). Cushing’s Disease: Surgical Management . In: Swearingen, B., Biller, B.M. (eds) Diagnosis and Management of Pituitary Disorders. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-264-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-264-9_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-922-2
Online ISBN: 978-1-59745-264-9
eBook Packages: MedicineMedicine (R0)